{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:46:26Z","timestamp":1773974786043,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003976","name":"The Israel National Institute for Health Policy Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003976","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Context<\/jats:title>\n                <jats:p>Opioid use disorder (OUD) poses significant public health problems that have increased dramatically, resulting in high rates of morbidity and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To minimize the risk of an opioid epidemic in Israel and be prepared, we evaluated physicians\u2019 objective knowledge, level of stigma, and approach to prescribing opioids, risk factors, and identification of patients with substance use disorder (SUD), as well as their knowledge about opioid maintenance treatment (OMT) for OUD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Anonymous computerized questionnaires were distributed nationally to physicians by the Israel Medical Association. Knowledge, stigma, and approach were scored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of only 249 responders, 58.6% prescribe opioids, 32.1% prescribe cannabis, and 18.5% daily encounter patients with SUD. Logistic regression found the high knowledge group had daily encounters with SUD (Odds Ratio (OR)\u2009=\u20093.5, 95% CI 1.7\u20137.1) and were familiar with OMT (OR\u2009=\u200910.1, 95% CI 3.5\u201329.0). The high stigma group was characterized by physicians who prescribe opioids (OR\u2009=\u20091.7, 95% CI 1.0\u20132.9), but who self-reported having limited knowledge regarding OMT (OR\u2009=\u20092, 95% CI 1.1\u20133.7). The high approach group was characterized by those who prescribe opioids (OR\u2009=\u200911.7, 95% CI 4.9\u201328), prescribe cannabis (OR\u2009=\u20092.1, 95% CI 1.0\u20134.3), self-report having limited knowledge regarding OMT (OR\u2009=\u200911.2, 95% CI 1.4\u201389) and self-report identifying SUD (OR\u2009=\u200932.5, 95% CI 4.1\u2013260).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>High stigma was most evident among physicians who prescribe opioids but, importantly, who had limited knowledge specifically regarding OMT. Gaps in knowledge and approach were observed. An educational intervention is highly recommended to reduce stigma and increase referrals of patients for OMT, the most effective treatment for opioid use disorder<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00869-9","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T11:19:04Z","timestamp":1694776744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stigma and level of familiarity with opioid maintenance treatment (OMT) among specialist physicians in Israel"],"prefix":"10.1186","volume":"20","author":[{"given":"Rozner","family":"Lihi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delayahu","family":"Yael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brill","family":"Silviu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sason","family":"Anat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weinstein","family":"Marsha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshan","family":"Stacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schreiber","family":"Shaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelson","family":"Miriam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peles","family":"Einat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"869_CR1","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/S0140-6736(99)03528-X","volume":"353","author":"H McQuay","year":"1999","unstructured":"McQuay H. Opioids in pain management. Lancet. 1999;353:2229\u201332.","journal-title":"Lancet"},{"key":"869_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/15360288.2015.1037521","volume":"29","author":"AB Kanouse","year":"2015","unstructured":"Kanouse AB, Compton P. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response. J Pain Palliat Care Pharmacother. 2015;29:102\u201314. https:\/\/doi.org\/10.3109\/15360288.2015.1037521.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"869_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.36076\/ppj.2018.4.309","volume":"1","author":"L Manchikanti","year":"2018","unstructured":"Manchikanti L, Sanapati J, Benyamin RM, Atluri S, Kaye AD, Hirsch JA. Reframing the prevention strategies of the opioid crisis: focusing on prescription opioids, fentanyl, and heroin epidemic. Pain Phys. 2018;1:309\u201326.","journal-title":"Pain Phys"},{"key":"869_CR4","unstructured":"Overdose Death Rates | National Institute on Drug Abuse (NIDA) [Internet]. [cited 2020 Jan 20]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"key":"869_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241\u20138. https:\/\/doi.org\/10.1056\/NEJMsa1406143.","journal-title":"N Engl J Med"},{"key":"869_CR6","unstructured":"Opioids - OECD [Internet]. 2016 [cited 2022 May 5]. Available from: https:\/\/www.oecd.org\/els\/health-systems\/opioids.htm"},{"key":"869_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/rapm-2020-101924","volume":"46","author":"O Miron","year":"2021","unstructured":"Miron O, Zeltzer D, Shir T, Balicer RD, Einav L, Feldman BS. Rising opioid prescription fulfillment among non-cancer and non-elderly patients-Israel\u2019s alarming example. Reg Anesth Pain Med. 2021;46:455\u20136.","journal-title":"Reg Anesth Pain Med"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000485033","volume":"23","author":"D Feingold","year":"2017","unstructured":"Feingold D, Goldberger N, Haklai Z, Lev-Ran S. Fatal overdoses of opioids in Israel 2005\u20132014. Eur Addict Res. 2017;23:276\u201383.","journal-title":"Eur Addict Res"},{"key":"869_CR9","unstructured":"Roshka P, Spivak P, Goldman K, Austin O. Summary of the activities of the Department for the Treatment of Addictions [Internet]. 2019. Available from: https:\/\/www.health.gov.il\/UnitsOffice\/HD\/MHealth\/mental\/addictions\/Documents\/mtl-addictions-2019.pdf"},{"key":"869_CR10","unstructured":"Davidovitch N, Kranzler Y, Miron O. Are we nearing an opioid epidemic in Israel? [Internet]. Jerusalem. 2023. Available from: www.taubcenter.org.il"},{"key":"869_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353:221\u20136.","journal-title":"Lancet"},{"key":"869_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113.","journal-title":"J Pain"},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1526-4637.2005.05020.x","volume":"6","author":"DT Cowan","year":"2005","unstructured":"Cowan DT, Wilson-Barnett DJ, Griffiths P, Vaughan DJA, Gondhia A, Allan LG. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med. 2005;6:113\u201321. https:\/\/doi.org\/10.1111\/j.1526-4637.2005.05020.x.","journal-title":"Pain Med"},{"key":"869_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5055\/jom.2006.0041","volume":"2","author":"M Baron","year":"2006","unstructured":"Baron M, McDonald P. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag. 2006;2:277\u201382.","journal-title":"J Opioid Manag"},{"key":"869_CR15","first-page":"321","volume-title":"A Pract Anesth","author":"M Angst","year":"2006","unstructured":"Angst M, Clark J. Opioid-induced hyperalgesia: a qualitative systematic review. In: Wylie C-D, editor. A Pract Anesth. 7th ed. Florida: CRC Press; 2006. p. 321\u201332.","edition":"7"},{"key":"869_CR16","unstructured":"Opioid Use Disorder > Fact Sheets > Yale Medicine [Internet]. [cited 2023 Sep 3]. Available from: https:\/\/www.yalemedicine.org\/conditions\/opioid-use-disorder"},{"key":"869_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1176\/appi.ps.201600056","volume":"68","author":"A Kennedy-Hendricks","year":"2017","unstructured":"Kennedy-Hendricks A, Barry CL, Gollust SE, Ensminger ME, Chisolm MS, McGinty EE. Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies. Psychiatr Serv. 2017;68:462\u20139. https:\/\/doi.org\/10.1176\/appi.ps.201600056.","journal-title":"Psychiatr Serv"},{"key":"869_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.drugalcdep.2017.12.037","volume":"185","author":"K Goodyear","year":"2018","unstructured":"Goodyear K, Haass-Koffler CL, Chavanne D. Opioid use and stigma: the role of gender, language and precipitating events. Drug Alcohol Depend. 2018;185:339\u201346.","journal-title":"Drug Alcohol Depend"},{"key":"869_CR19","first-page":"19","volume":"160","author":"L Rozner","year":"2021","unstructured":"Rozner L, Peles E. Stigma and misinformation about methadone maintenance therapy. Harefuah. 2021;160:19\u201323.","journal-title":"Harefuah"},{"key":"869_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/10550887.2016.1235404","volume":"36","author":"L Shidlansik","year":"2017","unstructured":"Shidlansik L, Adelson M, Peles E. Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel. J Addict Dis. 2017;36:30\u20137. https:\/\/doi.org\/10.1080\/10550887.2016.1235404.","journal-title":"J Addict Dis"},{"key":"869_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson","year":"2010","unstructured":"Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O\u2019Grady KE, et al. Why don\u2019t out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy. 2010;21:36\u201342.","journal-title":"Int J Drug Policy"},{"key":"869_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.addbeh.2006.09.008","volume":"32","author":"JB Luoma","year":"2007","unstructured":"Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, et al. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 2007;32:1331\u201346.","journal-title":"Addict Behav"},{"key":"869_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/jurban\/79.4.571","volume":"79","author":"S Stancliff","year":"2002","unstructured":"Stancliff S, Myers JE, Steiner S, Drucker E. Beliefs about methadone in an inner-city methadone clinic. J Urban Health. 2002;79:571\u20138.","journal-title":"J Urban Health"},{"key":"869_CR24","unstructured":"Lazker M, Zantzifer-Straichman Y, Lavi T, Landsheft Y, Mendelovich S. Medical cannabis unit report. 2022."},{"key":"869_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/08897077.2021.1901172","volume":"42","author":"LY Dhanani","year":"2021","unstructured":"Dhanani LY, Franz B. Attitudes toward and experiences working with patients who misuse opioids among board certified physicians in Ohio. Subst Abus. 2021;42:466\u201370.","journal-title":"Subst Abus"},{"key":"869_CR26","doi-asserted-by":"publisher","first-page":"108627","DOI":"10.1016\/j.drugalcdep.2021.108627","volume":"221","author":"EM Stone","year":"2021","unstructured":"Stone EM, Kennedy-Hendricks A, Barry CL, Bachhuber MA, McGinty EE. The role of stigma in U.S. primary care physicians\u2019 treatment of opioid use disorder. Drug Alcohol Depend. 2021;221:108627.","journal-title":"Drug Alcohol Depend"},{"key":"869_CR27","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1080\/08897077.2022.2060423","volume":"43","author":"E Gugala","year":"2022","unstructured":"Gugala E, Briggs O, Moczygemba LR, Brown CM, Hill LG. Opioid harm reduction: a scoping review of physician and system-level gaps in knowledge, education, and practice. Subst Abuse. 2022;43:972\u201387. https:\/\/doi.org\/10.1080\/08897077.2022.2060423.","journal-title":"Subst Abuse"},{"key":"869_CR28","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/pm\/pnw189","volume":"20","author":"TC Lin","year":"2019","unstructured":"Lin TC, Ger LP, Pergolizzi JV, Raffa RB, Wang JO, Ho ST. Knowledge, attitude and practice survey of prescribing opioids for chronic noncancer pain in Taiwan\u2014comparison of pain and non-pain physicians. Pain Med. 2019;20:2397\u2013410. https:\/\/doi.org\/10.1093\/pm\/pnw189.","journal-title":"Pain Med"},{"key":"869_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7517-9-20","volume":"9","author":"J Dooley","year":"2012","unstructured":"Dooley J, Asbridge M, Fraser J, Kirkland S. Physicians\u2019 attitudes towards office-based delivery of methadone maintenance therapy: results from a cross-sectional survey of Nova Scotia primary-care physicians. Harm Reduct J. 2012;9:20. https:\/\/doi.org\/10.1186\/1477-7517-9-20.","journal-title":"Harm Reduct J"},{"key":"869_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1521-0391.2012.00332.x","volume":"22","author":"RE Lawrence","year":"2013","unstructured":"Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Physicians\u2019 beliefs about the nature of addiction: a survey of primary care physicians and psychiatrists. Am J Addict. 2013;22:255\u201360. https:\/\/doi.org\/10.1111\/j.1521-0391.2012.00332.x.","journal-title":"Am J Addict"},{"key":"869_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/ajad.13023","volume":"29","author":"JJ Avery","year":"2020","unstructured":"Avery JJ, Avery JD, Mouallem J, Demner AR, Cooper J. Physicians\u2019 and attorneys\u2019 beliefs and attitudes related to the brain disease model of addiction. Am J Addict. 2020;29:305\u201312. https:\/\/doi.org\/10.1111\/ajad.13023.","journal-title":"Am J Addict"},{"key":"869_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08897077.2020.1748169","volume":"43","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O\u2019Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: a survey of hospitalist physicians. Subst Abuse. 2022;43:143\u201351. https:\/\/doi.org\/10.1080\/08897077.2020.1748169.","journal-title":"Subst Abuse"},{"key":"869_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/016128402753543027","volume":"23","author":"S Starr","year":"2002","unstructured":"Starr S, Campbell LR, Herrick CA. Factors affecting use of the mental health system by rural children. Issues Ment Health Nurs. 2002;23:291\u2013304.","journal-title":"Issues Ment Health Nurs"},{"key":"869_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jdd.12858","author":"E Schwarz","year":"2021","unstructured":"Schwarz E, Replogle K, McLemore K, Kohli R. Faculty and dental student knowledge, attitudes, and practices concerning the prescribing of opioids: informing curricular change. J Dent Educ. 2021. https:\/\/doi.org\/10.1002\/jdd.12858.","journal-title":"J Dent Educ"},{"key":"869_CR35","unstructured":"Recent data from patients\u2019 licenses - Medical Cannabis Unit (ICR) [Internet]. 2020. Available from: https:\/\/www.health.gov.il\/Subjects\/cannabis\/Documents\/licenses-status-september-2020.pdf"},{"key":"869_CR36","doi-asserted-by":"publisher","first-page":"e0266142","DOI":"10.1371\/journal.pone.0266142","volume":"17","author":"J Lim","year":"2022","unstructured":"Lim J, Farhat I, Douros A, Panagiotoglou D. Relative effectiveness of medications for opioid-related disorders: a systematic review and network meta-analysis of randomized controlled trials. PLoS ONE. 2022;17:e0266142.","journal-title":"PLoS ONE"},{"key":"869_CR37","unstructured":"Personnel in the Health Professions 2013, Ministry of health, information division, director of information and computing, division of medical professions, psychology division, director of nursing. [Internet]. 2014. Available from: https:\/\/www.health.gov.il\/NewsAndEvents\/SpokemanMesseges\/Documents\/18122014_1.pdf"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00869-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:32:20Z","timestamp":1700515940000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00869-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00869-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"9 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This national survey among all physicians who practice medicine in Israel was approved by the IRB of the Tel Aviv Sourasky Medical Center. All authors have approved the final version of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have declared that they do not have any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}